As part of the National Eye Institute’s consult service, Dr. Bishop examines and cares for people who are participating in clinical trials throughout the many Institutes and Centers of the NIH. This involves monitoring for medication and treatment side-effects, managing eye conditions both related and unrelated to NIH protocols, and performing eye surgery as needed. In addition, she is the co-lead on a 5-year longitudinal study of the ocular effects of Ebola on survivors in Liberia, part of the PREVAIL Ebola survivor study run by the National Institute of Allergy and Infectious Disease in partnership with the Liberian Ministry of Health. Dr. Bishop specializes in the treatment of ocular graft-versus-host disease, a condition affecting patients who have received a donor stem cell transplant in which the transplanted immune cells attack and destroy the tear-producing glands of the eye, resulting in severe dry eye. She is an expert on the ocular effects of cystinosis, an orphan disease, and plays an active role nationally and internationally to help formulate disease management guidelines, further research efforts, and improve clinician and patient education. As one of NEI’s key spokespeople, Dr. Bishop has promoted eye health in a multitude of media outlets, including print, radio, internet, and TV, and has helped produce educational materials for NEI. She has a special interest in bioethics, and has been an active member of the NIH Clinical Center Bioethics Committee for ten years.
From 2003 to 2006, Dr. Bishop provided refractive surgery to thousands of soldiers before their deployments to Afghanistan and Iraq, and cared for the community of active duty military, their families, and military retirees as the chief of the ophthalmology service at Darnall Army Community Hospital in Fort Hood, Texas. Prior to receiving her medical degree, she served as executive officer of a medical company for the Virginia Army National Guard, and completed active duty Army assignments as an administrator at Letterman U.S. Army Hospital in San Francisco and as a platoon leader and company executive officer of a medical company within the Second Infantry Division in South Korea.